Cargando…
IDF2022-0286 Presence of SARS-CoV-2 antibodies in asymptomatic type 1 diabetes; is there any association between glycemic control
Autores principales: | Fawwad, A., Tahir, B., Naseem, R., Malik, B., Siddiqui, I.A., Basit, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014361/ http://dx.doi.org/10.1016/j.diabres.2023.110510 |
Ejemplares similares
-
IDF2022-0819 Returning to normal after corona-virus pandemia, views of people with diabetes in Finland
por: Koski, S.
Publicado: (2023) -
Shape the future of diabetes at the IDF World Diabetes Congress 2022
Publicado: (2022) -
EHMTI-0286. Hemicrania epileptica: case report
por: Traverso, F, et al.
Publicado: (2014) -
IDF2022-0971 Comparison of severity of COVID amongst patients with newly detected diabetes vs. patients with pre-existing diabetes
por: Maheshwari, A., et al.
Publicado: (2023) -
Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016–2017
por: Basit, Abdul, et al.
Publicado: (2018)